Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Anti-inflammatory and antiproliferative actions of PPAR-gamma agonists on T lymphocytes derived from MS patients.
Comparative effectiveness of nonbiologic versus biologic disease-modifying antirheumatic drugs for rheumatoid arthritis.
Devices, drugs, and the Food and Drug Administration: increasing implications for ischemic stroke.
Mental health in the Syrian crisis: beyond immediate relief.
See All 4 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Devices, drugs, and the Food and Drug Administration: increasing implications for ischemic stroke.
Furlan AJ, Fisher M. Devices, drugs, and the Food and Drug Administration: increasing implications for ischemic stroke. Stroke. 2005 Feb; 36(2):398-9.
View in:
PubMed
subject areas
Brain Ischemia
Clinical Trials as Topic
Device Approval
Drug Approval
Equipment Safety
Humans
Legislation, Drug
Pharmaceutical Preparations
Product Surveillance, Postmarketing
Stroke
United States
United States Food and Drug Administration
authors with profiles
Marc Fisher MD